dsm-firmenich, a leading innovator in health, nutrition, and beauty, announced that it has secured market access for its 3-fucosyllactose (3-FL) human milk oligosaccharide (HMO) ingredient in the European Union (EU). The European Commission’s approval of 3-FL for use as a novel food ingredient in the EU is a result of a Novel Food application by Glycom A/S*. This breakthrough represents a major step towards enhancing market access for a wider portfolio of high-quality HMO products for use in the … [Read more...] about dsm-firmenich secures 3-fucosyllactose market access in the European Union
Ingredients
Kerry to acquire Lactase Enzymes Business
Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S (“Chr. Hansen”) and Novozymes A/S (“Novozymes”) (together the “Lactase Enzymes Business”) on a carve out basis¹. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process. The Lactase Enzymes Business … [Read more...] about Kerry to acquire Lactase Enzymes Business
Loryma launches plant-based egg substitute for baked goods
New compound replaces the features of egg and milk in vegan dough Zwingenberg/Germany, December 2023 – Ingredients specialist Loryma is expanding its wheat-based portfolio with a functional mix that is free of animal ingredients, as well as artificial colourings, flavourings, and preservatives. Vegan, wheat-based Lory® Stab perfectly replicates the technological properties of egg or milk in bakery products, resulting in a convincing visual appearance and authentic mouthfeel. Products made … [Read more...] about Loryma launches plant-based egg substitute for baked goods
